Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physostigmine vs Lorazepam for Adolescent Antimuscarinic Toxidrome
NCT03090620Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Mar 2017
- Primary completion
- Jul 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of physostigmine in anticholinergic toxidrome, sponsored by University of Colorado Denver. Started Mar 2017; status: completed.
02
Drugs
physostigmine
03
Conditions
anticholinergic toxidrome
Beyond the preview
Go deeper on NCT03090620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090620.